Tech adoption might slow down if the FDA layoffs shift responsibility for medical device and AI safety to hospitals.

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

In particular, the cuts could hurt the FDA's efforts to scale up its expertise and review capabilities in emerging areas like digital- and AI-based devices.

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...

The challenges in meeting regulatory requirements during a clinical ... panel during the Outsourcing Clinical Trials (OCT) Medical Devices 2025 conference, taking place in Munich, Germany, on ...

Saideep Nakka is a systems engineer with extensive experience in medical device innovation. His expertise spans high-speed ...

According to a press release from Saladax, Geffner-Atiya has successfully led regulatory strategies across large blue-chip corporations and pioneering start-ups, securing clearances under IVDRR, 510 ...

FDA Layoffs Shake Up Neuralink Trial Review Team. In a surprising move, the U.S. Food and Drug Administration (FDA) has laid off around 20 employees from its Office of Neurologica ...

The EU MDR certification is recognized globally for ensuring that medical devices meet stringent requirements ... and compliance with the highest regulatory standards. About Signifier Medical ...

The EU MDR certification is recognized globally for ensuring that medical devices meet stringent requirements ... and compliance with the highest regulatory standards. Signifier is a pioneer ...